SOLLICE BIOTECH Revenue and Competitors
Estimated Revenue & Valuation
- SOLLICE BIOTECH's estimated annual revenue is currently $2.3M per year.
- SOLLICE BIOTECH's estimated revenue per employee is $155,000
Employee Data
- SOLLICE BIOTECH has 15 Employees.
- SOLLICE BIOTECH grew their employee count by 0% last year.
SOLLICE BIOTECH's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Business Developper | Reveal Email/Phone |
SOLLICE BIOTECH Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is SOLLICE BIOTECH?
SOLLICE Biotech is a life sciences key partner, as leading creator, producer and high-quality provider of ACTIVE ingredients to benefit the cosmetics market. SOLLICE Biotech offers a full range of innovative high-performance and functional active ingredients, which are scientifically proven to provide personal care and innovative solutions.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SOLLICE BIOTECH News
Sollice Biotech, DSM, Ashland, The Lubrizol Corporation, ELEMENTIS PLC, Eastman Chemical Company, BASF SE, Clariant, Dow, Evonik Industries...
Bio-Based Cosmetics and Personal Care Ingredients Market to Witness Growth Acceleration | Sollice Biotech, DSM, Ashland.
... Chemical Company, ELEMENTIS PLC, Genomatica Inc., Nouryon, Sollice Biotech, Solvay, Lubrizol Corporation and other prominent players.
Other Companies in Toulouse
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.2M | 15 | -21% | N/A |
#2 | $2.4M | 16 | -11% | N/A |
#3 | $1M | 16 | -27% | N/A |
#4 | $1.4M | 16 | 78% | N/A |
#5 | $1.3M | 18 | 20% | N/A |